Plan B ruling is prescription for controversy

The Food and Drug Administration has denied an application by a pharmaceutical firm to make the emergency contraceptive known as Plan B available without a doctor’s prescription. That decision contravenes recent recommendations from an FDA advisory panel and from some FDA staff members who reviewed data on the so-called morning-after pill, which consists of two high doses of the hormone levonorgestrel.